Kevin P. Shortsle is an associate in the law firm of McDermott Will & Emery LLP and is based in the Firm's Chicago office. Kevin focuses his practice on intellectual property litigation, patent prosecution and counseling. Kevin concentrates his litigation practice on Hatch-Waxman and medical device matters. His recent representations involved the following:
- Knee, hip and spine surgical devices and techniques
- Rapaflo® (silodosin), a treatment for benign prostatic hyperplasia
- Pristiq® (desvenlafaxine), a treatment for depression
- Differin® (adapalene), a topical treatment for acne
- Solaraze® (diclofenac), a topical treatment for actinic keratosis
- EpiPen® (epinephrine auto injector), a treatment for anaphylaxis
Kevin handles all aspects of patent litigation, from pre-filing investigations through trial and appeal. He also has considerable experience counseling clients on issues related to patentability, validity and infringement. He prepares opinions concerning patentability of inventions, validity of patents and freedom-to-operate of products and technologies. Kevin has extensive experience preparing opinions related to pharmaceuticals, surgical devices, other medical device technologies, and food and beverage technologies. He prepares and prosecutes patents on a variety of subjects, including medical devices, diagnostic instrumentation, and food and beverage technologies.
